Financials
Financial year 2025
Worth noting
- The team shrank two years in a row.
Revenue
€ 32.1 million
▼ 5% vs 2024
Profit
Healthy€ 615,360
▼ 10% vs 2024
Debts
Low€ 5.1 million
▲ 81% vs 2024
Leo Pharma from Lier, company number BE0404780604, closed financial year 2025 with a result of € 615,360 after tax. For that financial year Leo Pharma recorded revenue of € 32.1 million and equity of € 9.9 million. Compared with financial year 2024, the result moved from € 684,266 to € 615,360. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 6, 2026.
What happened at Leo Pharma?
What happened at Leo Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Dilay Kücükkose stepped down as director. NBB
- Hilda DE SWAEF stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 615,360 (▼ 10% vs 2024). Source: NBB ↗
- Anders KRUGER stepped down as director. NBB
- Dilay Kücükkose became a director. NBB
- Anders KRUGER became a director. NBB
- Hilda DE SWAEF became a director. NBB
- New establishment in Lier. KBO
In short
From € 413,203 profit in 2021 to € 615,360 profit in 2025.
Paid € 1.5 million in corporate taxes since 2021.
Best year ever: 2023, with € 793,396 profit.
Pays suppliers within 67 days on average.
A new publication or filing at Leo Pharma? We notify you, reason included.
Follow Leo PharmaNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Hilda DE SWAEF
Director
since 2022 · until 2028
Anders KRUGER
Director
since 2024 · until 2025
Dilay Kücükkose
Director
since 2025 · until 2031
Establishments
Establishment units
Physical locations of this company
Duwijckstraat 17
2500 Lier
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 53 companies are registered at this address.
BLICKLE
€ 960,691 gross margin · 2025
DELTA BELGIUM
€ 98,557 gross margin · 2025
Flint Group Belgium
Rubaco Development
€ 16,982 gross margin · 2024
Lambrechts Car Service
€ 79,510 gross margin · 2025
+48 more
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US
Website info
Features
Security
Details
- Company number
- 0404.780.604
- VAT number
- BE 0404.780.604
- Registered office
- Duwijckstraat 17, 2500 Lier
- Names & denominations
- Leo Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 April 1967
- Peppol
- Active · Active since 15 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten